# Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS)

> **NCT05205785** · NA · TERMINATED · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 204 (actual)

## Conditions studied

- Irritable Bowel Syndrome
- IBS - Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Human Milk Oligosaccharide Mix
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05205785
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-22
- **Primary completion:** 2024-03-05
- **Final completion:** 2024-06-24
- **Target enrollment:** 204 (ACTUAL)
- **Why stopped:** Due to low enrollment, we have terminated this study
- **Last updated:** 2024-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05205785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05205785, "Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05205785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*